Elliott MJ - Search Results

1

Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2).

Elliott MJ, Woo P, Charles P, Long-Fox A, Woody JN, Maini RN. Elliott MJ, et al. Br J Rheumatol. 1997 May;36(5):589-93. doi: 10.1093/rheumatology/36.5.589. Br J Rheumatol. 1997. PMID: 9189062

2

Targeting TNF alpha for the therapy of rheumatoid arthritis.

Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M. Maini RN, et al. Clin Exp Rheumatol. 1994 Nov-Dec;12 Suppl 11:S63-6. Clin Exp Rheumatol. 1994. PMID: 7768056 Review.

3

TNF alpha as a therapeutic target in rheumatoid arthritis.

Feldmann M, Brennan FM, Elliott M, Katsikis P, Maini RN. Feldmann M, et al. Circ Shock. 1994 Aug;43(4):179-84. Circ Shock. 1994. PMID: 7895323 Review.

4

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.

Maini RN, Brennan FM, Williams R, Chu CQ, Cope AP, Gibbons D, Elliott M, Feldmann M. Maini RN, et al. Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S173-5. Clin Exp Rheumatol. 1993. PMID: 8391952 Review.

5

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.

Davis D, Charles PJ, Potter A, Feldmann M, Maini RN, Elliott MJ. Davis D, et al. Among authors: elliott mj. Br J Rheumatol. 1997 Sep;36(9):950-6. doi: 10.1093/rheumatology/36.9.950. Br J Rheumatol. 1997. PMID: 9376990 Clinical Trial.

6

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M. Maini RN, et al. Among authors: elliott mj. Arthritis Rheum. 1998 Sep;41(9):1552-63. doi: 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W. Arthritis Rheum. 1998. PMID: 9751087 Clinical Trial.

7

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN. Charles P, et al. Among authors: elliott mj. J Immunol. 1999 Aug 1;163(3):1521-8. J Immunol. 1999. PMID: 10415055 Clinical Trial.

8

TNF alpha is an effective therapeutic target for rheumatoid arthritis.

Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. Feldmann M, et al. Among authors: elliott mj. Ann N Y Acad Sci. 1995 Sep 7;766:272-8. doi: 10.1111/j.1749-6632.1995.tb26675.x. Ann N Y Acad Sci. 1995. PMID: 7486670 Review.

9

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.

Elliott MJ, Feldmann M, Maini RN. Elliott MJ, et al. Int J Immunopharmacol. 1995 Feb;17(2):141-5. doi: 10.1016/0192-0561(94)00092-3. Int J Immunopharmacol. 1995. PMID: 7544768 Review.

10

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M. Maini RN, et al. Among authors: elliott mj. Immunol Rev. 1995 Apr;144:195-223. doi: 10.1111/j.1600-065x.1995.tb00070.x. Immunol Rev. 1995. PMID: 7590814 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters